You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ATTENTION IN EVOKED RESPONSES AT HIGH-REPETITION RATES

    SBC: ABRATECH CORPORATION            Topic: N/A

    N/A

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  2. ATTENTION IN EVOKED RESPONSES AT HIGH-REPETITION RATES

    SBC: ABRATECH CORPORATION            Topic: N/A

    N/A

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  3. NON-INVASIVE BLOOD PHENYLALANINE MONITOR

    SBC: ACIONT, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Phenylketonuria (PKU) is a genetic deficiency of phenylalanine hydroxylase (PAH). Without PAH, the patient with PKU cannot metabolize phenylalanine (PHE) to tyrosine. The resulting accumulation of PHE and the accumulation of phenylpyruvate by a secondary metabolic pathway in the patient's blood produce neuropathies including severe mental retardation, behavior ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. IMPROVED NON-INVASIVE BLOOD GLUCOSE MONITORING DEVICE

    SBC: ACIONT, INC.            Topic: N/A

    The accurate measurement of blood glucose concentration is important in the management of diabetes. Current methods of glucose monitoring involve piercing the skin and collecting blood samples for analysis up to four times daily or more. Even the non-invasive Glucowatch tm glucose monitoring system requires twice daily blood collection for calibration. This original, innovative invention will decr ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. MULTIWELL COLORIMETRIC ASSAY FOR DNA REPAIR PROTEIN.

    SBC: ACTIVE MOTIF, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): DNA damages are key events during carcinogenesis. Deficiencies in repairing damaged DNA represent a poor prognosis during tumorigenesis and/or cancer treatment. Besides monitoring DNA damage formation, it would be helpful to monitor DNA repair protein activity. We propose to develop a new technology that allows for high-throughput and fast analysis of the most ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  6. FLUOROGENIC IMAGING MOLECULES FOR PROTEASE/KINASE ASSAYS

    SBC: ACTIVE MOTIF, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The aim of this proposal is to develop a series of fluorogenic imaging molecules, which can be easily delivered into viable cells and monitor cellular functions. The FIMs are composed of a peptide backbone containing a target site for a kinase or a protease. Some designs borrow from the molecular beacon approach and carry flurophore/quencher moieties, while oth ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  7. NOVEL SP1 & ER DNA-BINDING ASSAY FOR CANCER PROGNOSIS

    SBC: ACTIVE MOTIF, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): This proposal focuses on the development of multi-well ELISA-like assays to quantify DNA binding activity of two breast cancer prognosis markers, Sp1 and ER, with much more sensitivity and high throughput than standard DNA gel shift techniques. Such an approach has already been successfully applied to monitoring transcription factor activation by Active Motif ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. BETA-SECRETASE ASSAYS TO DISCOVER DRUGS FOR ALZHEIMER'S

    SBC: ACTIVESITE BIOTECH            Topic: N/A

    Alzheimer's disease (AD) is a debilitating mental disorder that results in a progressive loss of cognitive functions. However, there is no effective treatment for this disease. The neurotoxin AB peptide plays a central role in AD, involving increased production and accumulation of AB in brain amyloid plaques. Proteolytic processing of the amyloid precursor protein (APP) is required to generate AB, ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. BETA-SECRETASE ASSAYS TO DISCOVER DRUGS FOR ALZHEIMER'S

    SBC: ACTIVESITE BIOTECH            Topic: N/A

    Alzheimer's disease (AD) is a debilitating mental disorder that results in a progressive loss of cognitive functions. However, there is no effective treatment for this disease. The neurotoxin AB peptide plays a central role in AD, involving increased production and accumulation of AB in brain amyloid plaques. Proteolytic processing of the amyloid precursor protein (APP) is required to generate AB, ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  10. ACTIVITY-BASED PROTEOMICS FOR TOXICOLOGICAL ANALYSIS

    SBC: ACTIVX BIOSCIENCES            Topic: N/A

    DESCRIPTION (provided by applicant): Chemical probes will be developed to profile toxicities resulting from drug interactions. We have developed fluorescent probes that exclusively identify active members of the serine hydrolase super-family of enzymes. Using our technique, we can elucidate activity profiles of diseases, and broadly investigate interactions between the proteome and potential thera ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government